Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Research Progress of Lung Cancer Vaccines].
Fan H, Ge X, Zhou X, Li Y, Wang A, Hu Y. Fan H, et al. Among authors: ge x. Zhongguo Fei Ai Za Zhi. 2023 Sep 20;26(9):692-700. doi: 10.3779/j.issn.1009-3419.2023.106.19. Zhongguo Fei Ai Za Zhi. 2023. PMID: 37985155 Free PMC article. Review. Chinese.
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
Lu D, Ma Z, Huang D, Zhang J, Li J, Zhi P, Zhang L, Feng Y, Ge X, Zhai J, Jiang M, Zhou X, Simone CB 2nd, Neal JW, Patel SR, Yan X, Hu Y, Wang J. Lu D, et al. Among authors: ge x. Transl Lung Cancer Res. 2022 Jun;11(6):1119-1131. doi: 10.21037/tlcr-22-403. Transl Lung Cancer Res. 2022. PMID: 35832445 Free PMC article.
First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.
Zhai J, Lu J, Zhang Z, Wang Y, Li X, Zhang S, Mu S, Zhi X, Ge X, Lu D, Hu Y, Wang J. Zhai J, et al. Among authors: ge x. Cancer Med. 2022 May;11(10):2043-2055. doi: 10.1002/cam4.4589. Epub 2022 Mar 22. Cancer Med. 2022. PMID: 35315579 Free PMC article.
Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z, Yuan F, Chen R, Li Y, Ma J, Yan X, Wang L, Zhang F, Tao H, Guo D, Huang Z, Zhang S, Li X, Zhi X, Ge X, Hu Y, Wang J. Zhang Z, et al. Among authors: ge x. Front Immunol. 2020 Jun 10;11:1173. doi: 10.3389/fimmu.2020.01173. eCollection 2020. Front Immunol. 2020. PMID: 32587591 Free PMC article.
[Research Progress of Circular RNA in Lung Cancer].
Ge X, Zhang Z, Zhi X, Wang J. Ge X, et al. Zhongguo Fei Ai Za Zhi. 2020 Dec 20;23(12):1095-1100. doi: 10.3779/j.issn.1009-3419.2020.102.38. Zhongguo Fei Ai Za Zhi. 2020. PMID: 33357317 Free PMC article. Review. Chinese.
Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Zhang Z, Zhang F, Yuan F, Li Y, Ma J, Ou Q, Liu Z, Yang B, Wang L, Tao H, Zhang S, Li X, Zhi X, Ge X, Bao H, Wu X, Hu Y, Wang J. Zhang Z, et al. Among authors: ge x. Ther Adv Med Oncol. 2020 Nov 5;12:1758835920970049. doi: 10.1177/1758835920970049. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33224276 Free PMC article.
4,684 results